Notably, some gene pairs frequently prioritized by existing tools, such as APP–CD74, exhibited uniformly high expression across normal immune cell types, suggesting poor specificity for Tumor–Endothelial interactions (Table 4). The gene discussed is APP; the disease is neoplasm.